The determinants of R and D expenditures: A study of the Canadian biotechnology industry

Review of Industrial Organization

Volumn 17, Issue 4, 2000, Pages 357-370

  Cumming, Douglas J ^a   Macintosh, Jeffrey G ^b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Innovation; Research and development; Technology

Indexed keywords

BIOTECHNOLOGY; CANADA; RESEARCH;

BIOTECHNOLOGY; INDUSTRIAL INVESTMENT; INNOVATION; RESEARCH AND DEVELOPMENT;

CANADA;

EID: 0033677324     PISSN: 0889938X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1007864315687     Document Type: Article

References (30)

1. Economic welfare and the allocation of resources for invention
2. On the existence of optimal capital structure: Theory and evidence
3. Do strategic alliances create value?
4. Pre-emptive R and D, Rent Dissipation, and the 'leverage theory'
5. Genetically modified food
6. Buyer market structure and R and D effort: A simulataneous equations model
7. Deterrence by market sharing: A strategic incentive for licensing
8. Licensing and the theory of innovation
9. Pre-emptive patenting and the persistence of monopoly
10. Patents, recent trends and puzzles
11. Market structure, firm characteristics, and innovative activity
12. Consumer controversy and the funding of biotechnology research
13. Anticompetitive vertical integration by a dominant firm
14. Demand-pull and technological innovation: Schmookler revisited
15. The determinants of capital structure
16. Domestic R and D in the presence of multinational enterprises